OBJECTIVES: Mechanical ventilation is associated with overwhelming inflammatory responses that are associated with ventilator-induced lung injury (VILI) in patients with acute respiratory distress syndrome. The activation of adenosine A2A receptors has been reported to attenuate inflammatory cascades. HYPOTHESIS: The administration of A2A receptors agonist ameliorates VILI. METHODS: Rats were subjected to hemorrhagic shock and resuscitation as a first hit to induce systemic inflammation. The animals randomly received the selective A2A receptor agonist CGS-21680 or a vehicle control in a blinded fashion at the onset of resuscitation phase. They were then randomized to receive mechanical ventilation as a second hit with a high tidal volume of 20 mL/kg and zero positive end-expiratory pressure, or a low tidal volume of 6 mL/kg with positive end-expiratory pressure of 5 cm H2O. RESULTS: The administration of CGS-21680 attenuated lung injury as evidenced by a decrease in respiratory elastance, lung edema, lung injury scores, neutrophil recruitment in the lung, and production of inflammatory cytokines, compared with the vehicle-treated animals. CONCLUSIONS: The selective A2A receptor agonist may have a place as a novel therapeutic approach in reducing VILI.
OBJECTIVES: Mechanical ventilation is associated with overwhelming inflammatory responses that are associated with ventilator-induced lung injury (VILI) in patients with acute respiratory distress syndrome. The activation of adenosine A2A receptors has been reported to attenuate inflammatory cascades. HYPOTHESIS: The administration of A2A receptors agonist ameliorates VILI. METHODS:Rats were subjected to hemorrhagic shock and resuscitation as a first hit to induce systemic inflammation. The animals randomly received the selective A2A receptor agonist CGS-21680 or a vehicle control in a blinded fashion at the onset of resuscitation phase. They were then randomized to receive mechanical ventilation as a second hit with a high tidal volume of 20 mL/kg and zero positive end-expiratory pressure, or a low tidal volume of 6 mL/kg with positive end-expiratory pressure of 5 cm H2O. RESULTS: The administration of CGS-21680 attenuated lung injury as evidenced by a decrease in respiratory elastance, lung edema, lung injury scores, neutrophil recruitment in the lung, and production of inflammatory cytokines, compared with the vehicle-treated animals. CONCLUSIONS: The selective A2A receptor agonist may have a place as a novel therapeutic approach in reducing VILI.
Authors: J A McPherson; K G Barringhaus; G G Bishop; J M Sanders; J M Rieger; S E Hesselbacher; L W Gimple; E R Powers; T Macdonald; G Sullivan; J Linden; I J Sarembock Journal: Arterioscler Thromb Vasc Biol Date: 2001-05 Impact factor: 8.311
Authors: György Haskó; Da-Zhong Xu; Qi Lu; Zoltán H Németh; Jondavid Jabush; Tamara L Berezina; Sergey B Zaets; Balázs Csóka; Edwin A Deitch Journal: Crit Care Med Date: 2006-04 Impact factor: 7.598
Authors: Ognjen Gajic; Saqib I Dara; Jose L Mendez; Adebola O Adesanya; Emir Festic; Sean M Caples; Rimki Rana; Jennifer L St Sauver; James F Lymp; Bekele Afessa; Rolf D Hubmayr Journal: Crit Care Med Date: 2004-09 Impact factor: 7.598
Authors: Shahd Horie; Bairbre McNicholas; Emanuele Rezoagli; Tài Pham; Ger Curley; Danny McAuley; Cecilia O'Kane; Alistair Nichol; Claudia Dos Santos; Patricia R M Rocco; Giacomo Bellani; John G Laffey Journal: Intensive Care Med Date: 2020-07-11 Impact factor: 41.787